Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Bacterial and Fungal Infections in Persons Who Inject Drugs - Western New York, 2017.

Hartnett KP, Jackson KA, Felsen C, McDonald R, Bardossy AC, Gokhale RH, Kracalik I, Lucas T, McGovern O, Van Beneden CA, Mendoza M, Bohm M, Brooks JT, Asher AK, Magill SS, Fiore A, Blog D, Dufort EM, See I, Dumyati G.

MMWR Morb Mortal Wkly Rep. 2019 Jul 5;68(26):583-586. doi: 10.15585/mmwr.mm6826a2.

2.

Public Health Importance of Invasive Methicillin-sensitive Staphylococcus aureus Infections: Surveillance in 8 US Counties, 2016.

Jackson KA, Gokhale RH, Nadle J, Ray SM, Dumyati G, Schaffner W, Ham DC, Magill SS, Lynfield R, See I.

Clin Infect Dis. 2019 Apr 23. pii: ciz323. doi: 10.1093/cid/ciz323. [Epub ahead of print]

PMID:
31245810
3.

Vital Signs: Epidemiology and Recent Trends in Methicillin-Resistant and in Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections - United States.

Kourtis AP, Hatfield K, Baggs J, Mu Y, See I, Epson E, Nadle J, Kainer MA, Dumyati G, Petit S, Ray SM; Emerging Infections Program MRSA author group, Ham D, Capers C, Ewing H, Coffin N, McDonald LC, Jernigan J, Cardo D.

MMWR Morb Mortal Wkly Rep. 2019 Mar 8;68(9):214-219. doi: 10.15585/mmwr.mm6809e1.

4.

Trends in incidence of methicillin-resistant Staphylococcus aureus bloodstream infections differ by strain type and healthcare exposure, United States, 2005-2013.

See I, Mu Y, Albrecht V, Karlsson M, Dumyati G, Hardy DJ, Koeck M, Lynfield R, Nadle J, Ray SM, Schaffner W, Kallen AJ.

Clin Infect Dis. 2019 Feb 25. pii: ciz158. doi: 10.1093/cid/ciz158. [Epub ahead of print]

PMID:
30801635
5.

Burdens of Invasive Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureus Disease, Minnesota, USA.

Koeck M, Como-Sabetti K, Boxrud D, Dobbins G, Glennen A, Anacker M, Jawahir S, See I, Lynfield R.

Emerg Infect Dis. 2019 Jan;25(1):171-174. doi: 10.3201/eid2501.181146.

6.

Burden of Invasive Methicillin-Resistant Staphylococcus aureus Infections in Nursing Home Residents.

Grigg C, Palms D, Stone ND, Gualandi N, Bamberg W, Dumyati G, Harrison LH, Lynfield R, Nadle J, Petit S, Ray S, Schaffner W, Townes J, See I.

J Am Geriatr Soc. 2018 Aug;66(8):1581-1586. doi: 10.1111/jgs.15451. Epub 2018 Aug 10.

PMID:
30094828
7.

Invasive Methicillin-Resistant Staphylococcus aureus Infections Among Persons Who Inject Drugs - Six Sites, 2005-2016.

Jackson KA, Bohm MK, Brooks JT, Asher A, Nadle J, Bamberg WM, Petit S, Ray SM, Harrison LH, Lynfield R, Dumyati G, Schaffner W, Townes JM, See I.

MMWR Morb Mortal Wkly Rep. 2018 Jun 8;67(22):625-628. doi: 10.15585/mmwr.mm6722a2.

8.

Invasive Methicillin-Resistant Staphylococcus aureus USA500 Strains from the U.S. Emerging Infections Program Constitute Three Geographically Distinct Lineages.

Frisch MB, Castillo-Ramírez S, Petit RA 3rd, Farley MM, Ray SM, Albrecht VS, Limbago BM, Hernandez J, See I, Satola SW, Read TD.

mSphere. 2018 May 2;3(3). pii: e00571-17. doi: 10.1128/mSphere.00571-17. eCollection 2018 May-Jun.

9.

Racial Disparities in Invasive Methicillin-resistant Staphylococcus aureus Infections, 2005-2014.

Gualandi N, Mu Y, Bamberg WM, Dumyati G, Harrison LH, Lesher L, Nadle J, Petit S, Ray SM, Schaffner W, Townes J, McDonald M, See I.

Clin Infect Dis. 2018 Sep 28;67(8):1175-1181. doi: 10.1093/cid/ciy277.

10.

Pathogen Distribution and Antimicrobial Resistance Among Pediatric Healthcare-Associated Infections Reported to the National Healthcare Safety Network, 2011-2014.

Lake JG, Weiner LM, Milstone AM, Saiman L, Magill SS, See I.

Infect Control Hosp Epidemiol. 2018 Jan;39(1):1-11. doi: 10.1017/ice.2017.236. Epub 2017 Dec 18.

11.

Socioeconomic Factors Explain Racial Disparities in Invasive Community-Associated Methicillin-Resistant Staphylococcus aureus Disease Rates.

See I, Wesson P, Gualandi N, Dumyati G, Harrison LH, Lesher L, Nadle J, Petit S, Reisenauer C, Schaffner W, Tunali A, Mu Y, Ahern J.

Clin Infect Dis. 2017 Mar 1;64(5):597-604. doi: 10.1093/cid/ciw808.

12.

Impact of removing mucosal barrier injury laboratory-confirmed bloodstream infections from central line-associated bloodstream infection rates in the National Healthcare Safety Network, 2014.

See I, Soe MM, Epstein L, Edwards JR, Magill SS, Thompson ND.

Am J Infect Control. 2017 Mar 1;45(3):321-323. doi: 10.1016/j.ajic.2016.10.015. Epub 2016 Nov 14.

13.

Clinical Correlates of Surveillance Events Detected by National Healthcare Safety Network Pneumonia and Lower Respiratory Infection Definitions-Pennsylvania, 2011-2012.

See I, Chang J, Gualandi N, Buser GL, Rohrbach P, Smeltz DA, Bellush MJ, Coffin SE, Gould JM, Hess D, Hennessey P, Hubbard S, Kiernan A, O'Donnell J, Pegues DA, Miller JR, Magill SS.

Infect Control Hosp Epidemiol. 2016 Jul;37(7):818-24. doi: 10.1017/ice.2016.74. Epub 2016 Apr 13.

14.
15.

Completeness of Methicillin-Resistant Staphylococcus aureus Bloodstream Infection Reporting From Outpatient Hemodialysis Facilities to the National Healthcare Safety Network, 2013.

Nguyen DB, See I, Gualandi N, Shugart A, Lines C, Bamberg W, Dumyati G, Harrison LH, Lesher L, Nadle J, Petit S, Ray SM, Schaffner W, Townes J, Njord L, Sievert D, Thompson ND, Patel PR.

Infect Control Hosp Epidemiol. 2016 Feb;37(2):205-7. doi: 10.1017/ice.2015.265. Epub 2015 Nov 11.

16.

Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infections (MBI-LCBI): Descriptive Analysis of Data Reported to National Healthcare Safety Network (NHSN), 2013.

Epstein L, See I, Edwards JR, Magill SS, Thompson ND.

Infect Control Hosp Epidemiol. 2016 Jan;37(1):2-7. doi: 10.1017/ice.2015.245. Epub 2015 Oct 12.

17.

Emerging Infections Program as Surveillance for Antimicrobial Drug Resistance.

Fridkin SK, Cleveland AA, See I, Lynfield R.

Emerg Infect Dis. 2015 Sep;21(9):1578-81. doi: 10.3201/eid2109.150512.

18.

Outbreak of Clostridium difficile Infections at an Outpatient Hemodialysis Facility-Michigan, 2012-2013.

See I, Bagchi S, Booth S, Scholz D, Geller AI, Anderson L, Moulton-Meissner H, Finks JL, Kelley K, Gould CV, Patel PR.

Infect Control Hosp Epidemiol. 2015 Aug;36(8):972-4. doi: 10.1017/ice.2015.90. Epub 2015 Apr 27.

19.

Two new chemical constituents from the stem bark of Garcinia mangostana.

See I, Ee GC, Teh SS, Kadir AA, Daud S.

Molecules. 2014 Jun 4;19(6):7308-16. doi: 10.3390/molecules19067308.

20.

A new coumarin from Calophyllum hosei.

Daud SB, Ee GC, Malek EA, Teh SS, See I.

Nat Prod Res. 2014;28(19):1534-8. doi: 10.1080/14786419.2014.924001. Epub 2014 Jun 4.

PMID:
24897077
21.

Infection control and bloodstream infection prevention: the perspective of patients receiving hemodialysis.

See I, Shugart A, Lamb C, Kallen AJ, Patel PR, Sinkowitz-Cochran RL.

Nephrol Nurs J. 2014 Jan-Feb;41(1):37-9, 50; quiz 40.

22.

A new furanoxanthone from Garcinia mangostana.

Ee GC, See I, Teh SS, Daud S.

J Asian Nat Prod Res. 2014;16(7):790-4. doi: 10.1080/10286020.2014.901313. Epub 2014 Mar 27.

PMID:
24670077
23.

NAP1 strain type predicts outcomes from Clostridium difficile infection.

See I, Mu Y, Cohen J, Beldavs ZG, Winston LG, Dumyati G, Holzbauer S, Dunn J, Farley MM, Lyons C, Johnston H, Phipps E, Perlmutter R, Anderson L, Gerding DN, Lessa FC.

Clin Infect Dis. 2014 May;58(10):1394-400. doi: 10.1093/cid/ciu125. Epub 2014 Mar 5.

24.

Outbreak of Tsukamurella species bloodstream infection among patients at an oncology clinic, West Virginia, 2011-2012.

See I, Nguyen DB, Chatterjee S, Shwe T, Scott M, Ibrahim S, Moulton-Meissner H, McNulty S, Noble-Wang J, Price C, Schramm K, Bixler D, Guh AY.

Infect Control Hosp Epidemiol. 2014 Mar;35(3):300-6. doi: 10.1086/675282.

25.

Emergency department visits and hospitalizations for digoxin toxicity: United States, 2005 to 2010.

See I, Shehab N, Kegler SR, Laskar SR, Budnitz DS.

Circ Heart Fail. 2014 Jan;7(1):28-34. doi: 10.1161/CIRCHEARTFAILURE.113.000784. Epub 2013 Dec 3.

26.

Incidence and pathogen distribution of healthcare-associated infections in pilot hospitals in Egypt.

See I, Lessa FC, ElAta OA, Hafez S, Samy K, El-Kholy A, El Anani MG, Ismail G, Kandeel A, Galal R, Ellingson K, Talaat M.

Infect Control Hosp Epidemiol. 2013 Dec;34(12):1281-8. doi: 10.1086/673985. Epub 2013 Oct 30.

27.

Mucosal barrier injury laboratory-confirmed bloodstream infection: results from a field test of a new National Healthcare Safety Network definition.

See I, Iwamoto M, Allen-Bridson K, Horan T, Magill SS, Thompson ND.

Infect Control Hosp Epidemiol. 2013 Aug;34(8):769-76. doi: 10.1086/671281. Epub 2013 Jun 27.

PMID:
23838215
28.

Fibrillar collagen clamps lung mesenchymal cells in a nonproliferative and noncontractile phenotype.

Schuliga MJ, See I, Ong SC, Soon L, Camoretti-Mercado B, Harris T, Stewart AG.

Am J Respir Cell Mol Biol. 2009 Dec;41(6):731-41. doi: 10.1165/rcmb.2008-0361OC. Epub 2009 Mar 27.

PMID:
19329552
29.

"Chap Kaki Tiga" a possible cause of upper gastrointestinal haemorrhage.

See IO.

Med J Malaysia. 1996 Mar;51(1):159-60. No abstract available.

30.

Supplemental Content

Support Center